India government launches its own brand to sell cheap generic drugs

India is well known to be one of the “workhorse” in generic production. Despite the comparable reasonably priced drugs in global market, the lower income population is still having difficulty in affording them during treatments. As an initiative to provide more holistic healthcare services for all, Indian government has decided to step in and control generic prices by purchasing and …

Results, Benefit Assessment, Price, negotiation, Pharma Pricing

Latest results of early benefit assessments and price negotiations

At Pharma Pricing 2014, Meriem Bouslouk PhD, Pharmaceuticals Department, Federal Joint Committee Germany gave a presentation “Latest results of early benefit assessments and price negotiations” Download and learn: Assessment principles- Key points Consultations with the G-BA Orphan Drugs Price negotiations¬†/ Arbitration Decisions / OPT-OUTS G-BA vision at European level Licensing and reimbursing: harmonization? Download presentation Found this interesting? You might …

Download: Scarcity, value and price

Pharma Pricing & Market Access Europe 2013 addressed the critical policy issues in developing the optimum pricing strategy for pharmaceutical products last March.  Discussions revolved around topics involving policy challenges in market access, HTA practice effecting the market, and how innovative pricing and risk sharing models between industry and payers have changed. At the event, Jim Furniss, Senior VP, Market …